Actively Recruiting
Is Repetitive Transcranial Magnetic Stimulation Effective in Reducing Endometriosis-associated Pain
Led by University of Ottawa · Updated on 2024-04-15
152
Participants Needed
1
Research Sites
166 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this research is to improve pain outcomes for the over 500K Canadian women, girls and gender-diverse individuals who are newly diagnosed with endometriosis each year. Chronic pain that persists after interventions for endometriosis is a huge problem. There is some evidence that endometriosis-associated pain (EAP) is, at least to some extent, associated with changes in pain physiology, particularly central sensitization of pain. There is currently no effective evidence-informed intervention that addresses EAP. Yet a recent feasibility trial on a repetitive transcranial magnetic stimulation (rTMS) intervention demonstrated promising results compared to a sham intervention for reducing pain in a sample with EAP. The objectives of this trial are: 1. to evaluate the effectiveness of an rTMS intervention for pain reduction among those with recalcitrant post-operative EAP, 2. to inform on the utility of a long (10 session) vs short (5 session) protocol for pain reduction among those with recalcitrant post-operative EAP 3. to determine if any improvements in pain observed 30 days after an rTMS intervention are retained 6 months later 4. to identify physical and psychosocial mediators that impact the successful reduction of pain among patients with EAP treated using rTMS. 5. to describe patients' perceptions of and satisfaction with rTMS as an intervention for EAP.
CONDITIONS
Official Title
Is Repetitive Transcranial Magnetic Stimulation Effective in Reducing Endometriosis-associated Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women, girls, and gender-diverse individuals aged 18 to 60 years
- Self-reported endometriosis-associated pain greater than 3 on a 0-10 scale that persists after medical or surgical treatment
You will not qualify if you...
- Contraindications to rTMS such as metal implants around the head or neck, pacemaker, or family history of epilepsy
- Pain caused by other known conditions like infections, thyroid disease, autoimmune diseases, or gastrointestinal disease
- Experiencing more severe pain outside the pelvic area than the pain caused by endometriosis
- Currently pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
McLean Function Measurement Lab
Ottawa, Ontario, Canada, K1S1S2
Actively Recruiting
Research Team
A
Anne-Marie MacDonald, MSc
CONTACT
F
Flavia Ignacio Antonio, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here